13-17 April 2016
EASL International Liver Congress & the Liver Forum
EASL was founded 50 years ago. This year there is an expected attendance at the congress of over 10,000 delegates. This congress attracts hepatology experts with expertise in global research, education, advocacy and influence.
Two of our senior science advisors - Chief Scientific Officer – Professor Tim St Pierre and Clinical Research Manager - Dr Sherif Boulos will be attending both the EASL conference and the fourth Liver Forum which takes place prior to the congress. They will be coordinating high level clinical discussions with potential collaborators, experts, and KOL’s in the liver community on current, future pipeline, and clinical trial services for the HepaFat-Scan and FerriScan technologies.
Professor St Pierre welcomes any opportunity to discuss the FerriScan’s services for patients with Thalassaemia, Sickle Cell disease, Diamond Blackfan Anaemia, Haemochromatosis, Hyperferritenemia or Myelodysplastic Sydromes. Dr Boulos is happy to showcase the HepaFat Scan service for patient management with NAFLD / NASH.
For further information on the congress please click here.